Full Text
EE468 Cost-Effectiveness Analysis of Baricitinib Compared to Standard of Care in Improving Symptoms of Alopecia Areata for the Patients in the U.S. From the Healthcare Payer Perspective

Abstract

Authors

Jean Lee

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×